Huigu Pharmaceutical Group, headquartered in Tianhe North, Guangzhou, is a modern pharmaceutical enterprise integrating R&D, intelligent manufacturing, and marketing. Focused on the children's health sector, the group is committed to building a nationally recognized pharmaceutical brand. Its predecessor was established in 1993, and the group now owns multiple wholly-owned and holding subsidiaries, including Hainan Huigu Pharmaceutical Co., Ltd. and Guangdong Ketai Dingrun Pharmaceutical Technology Co., Ltd. Its core production base, Hainan Huigu Pharmaceutical, is located in Haikou and has been recognized as a High-Tech Enterprise and a "Specialized and Sophisticated" Enterprise in Hainan Province. It holds 7 invention patents and has been consecutively rated as a Grade A Tax Credit Enterprise.

   Jukesheng® Lysine and Zinc Granules (Sugar-Free) is the group's flagship pediatric product. As an OTC drug with a National Drug Approval Number, it provides combined supplementation of lysine and zinc, is sugar-free, contains no artificial colors or preservatives, and features clear age-specific dosage recommendations. It is indicated for the prevention and treatment of diseases in children and adolescents caused by lysine and zinc deficiencies. With over two decades of professional dedication, the product has been included in authoritative evidence-based medical references such as the Clinical Application Guide for Children's Drugs in China and has been recognized as a High-Tech Product in Hainan Province. Currently, the product is available across numerous medical institutions, chain pharmacies, and major e-commerce platforms nationwide, with annual sales exceeding 100 million sachets. It has received multiple industry accolades, including the China Pharmaceutical Brand Rising Star Award, the Best Popularity Award for Chinese Family Essential Medicines, the Preferred Zinc Supplement Brand by the Good Product Review Panel, and the Well-Known Brand in Pediatric Medicine Category on JD Health.

   In terms of quality systems, the group strictly adheres to GMP standards and maintains an internal quality control system that exceeds national requirements. Since its launch, Jukesheng® has passed all national and provincial supervisory inspections. In R&D and innovation, the group pursues independent research while actively engaging in industry-university-research collaborations, with a continued focus on controlled-release and sustained-release formulation technologies. It fully considers long-term medication scenarios and places great emphasis on the safety of prolonged use. Leveraging the brand momentum of Jukesheng®, the product pipeline is being systematically expanded into a comprehensive product portfolio, building an all-encompassing health industry landscape.

   HuiGu Pharmaceuticals takes quality as its cornerstone, actively fulfills its social responsibilities, and has long been committed to supporting the growth of adolescents and assisting vulnerable groups. Looking ahead, the Group will uphold its business philosophy of "professional dedication and pursuit of excellence," continue to deepen its presence in the children's health industry and the high-end controlled- and sustained-release formulation sector, and strive to become a benchmark pharmaceutical enterprise in China's children's nutritional health sector. With scientific, safe, and high-quality products, it is dedicated to safeguarding the healthy growth of children and adolescents.